Company Profile
Hypera is a pharmaceutical company in Brazil. The company provides sweeteners products under the Adocyl, finn, and Zero-cal brands. Its portfolio also includes analgesics and anti-inflammatories products under the Doril, Atroveran, Calminex, Alivium, Buscopan, Buscofem, geloll, Torsilax, Neosaldina, and naprohax brands, and cold and flu remedies and decongestants products under BENEGRIO, Rinosoro, Blu, Neosoro, Coristina, APRACUR, and Fluviral brands.
It offers antihistamines products under Alektos, Histamin, Polaramine, PredSim, and Desrinite brands. Its portfolio also includes antiseptics products under Merthiolate brand, Herbal medicine products under Maracugina, Eparema, Tamarine, and Naturetti brands, and gastrointestinal products under Dramin, Estomazil, Engov, Lacto-purga, gastrol, Epocler, Bifilax, and Pepsamar brands generics products under neo quimica brand.
Its portfolio also includes skicare products under episol, epidrat, simple organic, and bioage brands, supplements and vitamins products Addera, Biotonico Fontoura, Colflex, and Vitasay brands, and products under Nebacetin, Cepacol, ESCABIN, Mirrorelax, Ammy, Nesina, and Diprospan brands. Founded in 1999 and headquartered in São Paulo, Brazil, Hypera was formerly known as Hypermarcas S.A. before rebranding in February 2018.